Latest Articles

Kimchi is a dietary staple of Korean diets, and for good reason, according to research.

Associate Professor Qing Zhong shared insights on AI breakthroughs in proteomics and multiomics, challenges in data sharing and his vision for a high-resolution lens on biology that could redefine science and healthcare.

In this article, Momin Shah discusses how to ensure that NGS protocols are optimized from the outset to save time and costs on new research projects.

This article explores how multi-agent generative AI frameworks are revolutionizing drug development.

In this interview, Dr. Eitan Schechtman explains how his lab is addressing some of the common misconceptions about sleep and the questions that keep even a sleep expert awake at night.

Functional genomics can help deconvolute the link between genotype and phenotype in disease, revealing new drug targets and progressing understanding of existing drugs.

Researchers have developed a new electrically active biomaterial that can be transplanted into the body to improve recovery following central nervous system injuries. The material acts as a scaffold that also provides electrical stimulation.

High demand and supply shortages of weight loss drugs have presented opportunities for counterfeit drugs to enter the market. So, what are the dangers of counterfeits? And what can consumers look out for?

AI tools are revolutionizing neuroscience, enabling researchers to predict study outcomes with 86% accuracy and uncover novel connections across brain studies. This approach enhances hypothesis generation and optimizes resource allocation.

Incretin-mimetic drugs contribute to dramatic weight loss, but this does not solely mean fat loss. In this article, we explore the impact of incretin-mimetic drugs on muscle health and what can be done to limit these severe side effects.